ShareKhan has recommended `Buy` on Glenmark Pharmaceuticals with a price target of Rs 371 as against the current market price (CMP) of Rs 291 in its report dated Feb. 02, 2011. The broking house gave the following rationale: Lower US sales make Q3FY2011 grim: Glenmark Pharmaceuticals (Glenmark) reported a robust 21.4% growth on its base business (ex-licensing income) in Q3FY2011
Posts Tagged ‘current’
Firstcall recommends `Buy` on Wipro
Firstcall has recommended `Buy` on Wipro with a price target of Rs 495 as against the current market price (CMP) of Rs 430 in its report dated Feb. 02, 2011.
Prabhudas Lilladher maintains `Accumulate` on Great Offshore
Prabhudas Lilladher has recommended `Accumulate` on Great Offshore with a price target of Rs 377 as against the current market price (CMP) of Rs 299 in its report dated Feb. 3, 2011.
Kotak Sec maintains `Reduce ` on Hero Honda
Kotak Securities has recommended `Reduce` on Hero Honda Motors with a price target of Rs 1.576 as against the current market price (CMP) of Rs 1,523 in its report dated Feb.
Anand Rathi recommends `Hold` on Dabur India
Anand Rathi Securities has recommended ` Hold ` on Dabur India with a price target of Rs 110 as against the current market price (CMP) of Rs 94 in its report dated Feb. 1, 2011.
Anand Rathi recommends `Buy` on Colgate Palmolive
Anand Rathi Securities has recommended ` Buy ` on Colgate Palmolive with a price target of Rs 1,020 as against the current market price (CMP) of Rs 824 in its report dated Feb. 1, 2011.
Anand Rathi Sec recommends `Hold` on Rolta India
Anand Rathi Securities has recommended ` Hold ` on Rolta India with a price target of Rs 170 as against the current market price (CMP) of Rs 135 in its report dated Feb. 1, 2011.
Emkay maintains `Buy` on JK Paper
Emkay has recommended ` Buy ` on JK Paper with a price target of Rs 84 as against the current market price (CMP) of Rs 53 in its report dated Jan 31, 2011. The broking house gave the following rationale: 18% revenue growth driven by 8% growth in volumes and 10% in realisations: JK Paper`s Q3FY11 revenues increased by 18% yoy to Rs 3.1 billion which was in line with our estimates of Rs 3.1 billion.
Emkay maintains `Hold` on NTPC
Emkay has recommended ` Hold ` on NTPC with a price target of Rs 190 as against the current market price (CMP) of Rs 188 in its report dated Jan 31, 2011. The broking house gave the following rationale: > APAT of Rs 23.2 bn (prior year sales not adj.) is higher than est
Wockhardt swings to profit in Q3
Pharmaceutical and Biotechnology major, Wockhardt today swung to profit for the third quarter ended Dec. 2010.
KJMC maintains `Buy` on Jyoti Structures
KJMC has recommended ` Buy ` on Jyoti Structures with a price target of Rs 160 as against the current market price (CMP) of Rs 110 in its report dated Feb.
Commexes turnover to cross Rs 112 lakh crore
The trading turnover of all commodity exchanges in India is expected to grow by 44.24% in the current fiscal to reach Rs 112,000 billion, according to the market regulator Forward Market Commission (FMC) . “The overall trading turnover of commodity exchanges in the country will be more than 112 lakh crore in the current fiscal,“ FMC Chairman B C Khatua told reporters here today on the sidelines of an event organised by industry body Assocham. He said during the last fiscal, the commexes in the country…
Asit C Mehta recommends `Accumulate` on TRF
Asit C Mehta has recommended ` Accumulate ` on TRF with a price target of Rs 569 as against the current market price (CMP) of Rs 499 in its report dated Feb. 02, 2011
Emkay maintains `Buy` on Ballarpur Industries
Emkay has recommended ` Buy ` on Ballarpur Industries with a price target of Rs 42 as against the current market price (CMP) of Rs 32 in its report dated Feb. 2, 2011. The broking house gave the following rationale: Q2FY11 results, though in line with estimates with APAT of Rs 480 mn (+5% yoy), disappointed with EBITDA margins at 19.3% (-330 bps yoy / -120 bps qoq), lowest since FY07.



Posted in
Tags: